A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial
Open angle, pseudoexfoliative or pigmentary glaucoma
IOP at preoperative visit of ≥ 20mmHg and ≤ 40mmHg
Visual field mean deviation score of -3dB or worse
Area of healthy, free and mobile conjunctiva in the target quadrant
Angle closure glaucoma
Congenital, neovascular or other secondary glaucomas
Previous intraocular surgery, with the exception of uncomplicated cataract surgery
Previous glaucoma shunt/valve in the target quadrant
Single group
VisiPlate Glaucoma Implant
DeviceImplant (micro-shunt) for glaucoma patients
Proportion of subjects (eyes) achieving a ≥ 20% reduction in mean diurnal intraocular pressure
The eye is filled with a special fluid. The intraocular pressure is the amount of fluid that builds up in the eye. The primary outcome is the number of people whose eye pressure went down by at least 20%.
Percentage change in mean diurnal IOP
How much the average eye pressure during the day went up or down, shown as a percent.
Click on the lead sponsor to view all of their trials.
